| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.
|
Lancet
|
2010
|
12.92
|
|
2
|
Meta-analysis of the impact of 9 medication classes on falls in elderly persons.
|
Arch Intern Med
|
2009
|
5.36
|
|
3
|
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
|
Ann Intern Med
|
2009
|
3.03
|
|
4
|
Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis.
|
Chest
|
2006
|
2.37
|
|
5
|
Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer.
|
Value Health
|
2012
|
2.06
|
|
6
|
Measuring health-related quality of life in tuberculosis: a systematic review.
|
Health Qual Life Outcomes
|
2009
|
1.85
|
|
7
|
Antibiotic use in children is associated with increased risk of asthma.
|
Pediatrics
|
2009
|
1.68
|
|
8
|
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.
|
Arch Intern Med
|
2006
|
1.68
|
|
9
|
The economic impact of obstructive sleep apnea.
|
Lung
|
2007
|
1.65
|
|
10
|
Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications.
|
Pharmacoeconomics
|
2005
|
1.50
|
|
11
|
Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability.
|
Am J Hum Genet
|
2010
|
1.47
|
|
12
|
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions.
|
CMAJ
|
2005
|
1.42
|
|
13
|
De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival.
|
Pediatr Blood Cancer
|
2014
|
1.39
|
|
14
|
Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
|
Thorax
|
2013
|
1.39
|
|
15
|
Health state utilities in latent and active tuberculosis.
|
Value Health
|
2008
|
1.34
|
|
16
|
The cost effectiveness of human papillomavirus vaccines: a systematic review.
|
Drugs
|
2012
|
1.30
|
|
17
|
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy.
|
CMAJ
|
2006
|
1.24
|
|
18
|
Physical activity as a mediator of the impact of chronic conditions on quality of life in older adults.
|
Health Qual Life Outcomes
|
2007
|
1.13
|
|
19
|
Infliximab treatment of rheumatoid arthritis and Crohn's disease.
|
Ann Pharmacother
|
2003
|
1.10
|
|
20
|
Now that we know what's BeSt, what is good value for the money?
|
Arthritis Rheum
|
2009
|
1.07
|
|
21
|
Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study.
|
PLoS One
|
2012
|
1.05
|
|
22
|
The independent contribution of executive functions to health related quality of life in older women.
|
BMC Geriatr
|
2010
|
1.04
|
|
23
|
Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women.
|
Diabetes Care
|
2011
|
1.03
|
|
24
|
Effects of prescription adaptation by pharmacists.
|
BMC Health Serv Res
|
2010
|
1.03
|
|
25
|
Bayesian and classical estimation of mixed logit: An application to genetic testing.
|
J Health Econ
|
2008
|
1.03
|
|
26
|
Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment.
|
Genet Med
|
2012
|
1.02
|
|
27
|
Preference-based quality of life of end-stage ankle arthritis treated with arthroplasty or arthrodesis.
|
Foot Ankle Int
|
2010
|
0.99
|
|
28
|
Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study.
|
Diabetes Care
|
2013
|
0.98
|
|
29
|
After patients are diagnosed with knee osteoarthritis, what do they do?
|
Arthritis Care Res (Hoboken)
|
2010
|
0.96
|
|
30
|
Parental perceived value of a diagnosis for intellectual disability (ID): a qualitative comparison of families with and without a diagnosis for their child's ID.
|
Am J Med Genet A
|
2009
|
0.95
|
|
31
|
Evaluating the labour costs associated with pharmacy adaptation services in British Columbia.
|
Can Pharm J (Ott)
|
2012
|
0.94
|
|
32
|
The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status.
|
Qual Life Res
|
2008
|
0.94
|
|
33
|
Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
|
Sex Transm Infect
|
2010
|
0.94
|
|
34
|
Cost effectiveness of herpes zoster vaccine in Canada.
|
Pharmacoeconomics
|
2009
|
0.93
|
|
35
|
An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.
|
Drugs
|
2005
|
0.93
|
|
36
|
A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management.
|
Patient Prefer Adherence
|
2010
|
0.93
|
|
37
|
A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events.
|
Influenza Other Respir Viruses
|
2012
|
0.93
|
|
38
|
A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy.
|
J Clin Epidemiol
|
2009
|
0.93
|
|
39
|
Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis.
|
J Rheumatol
|
2008
|
0.93
|
|
40
|
Valuing health for clinical and economic decisions: directions relevant for rheumatologists.
|
J Rheumatol
|
2011
|
0.91
|
|
41
|
Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients.
|
Health Qual Life Outcomes
|
2006
|
0.90
|
|
42
|
Falls-related self-efficacy is independently associated with quality-adjusted life years in older women.
|
Age Ageing
|
2011
|
0.90
|
|
43
|
Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea.
|
Sleep Breath
|
2009
|
0.90
|
|
44
|
Sustained cognitive and economic benefits of resistance training among community-dwelling senior women: a 1-year follow-up study of the Brain Power study.
|
Arch Intern Med
|
2010
|
0.89
|
|
45
|
Future impact of various interventions on the burden of COPD in Canada: a dynamic population model.
|
PLoS One
|
2012
|
0.88
|
|
46
|
Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada.
|
Value Health
|
2010
|
0.88
|
|
47
|
Pharmacists' preferences for providing patient-centered services: a discrete choice experiment to guide health policy.
|
Ann Pharmacother
|
2010
|
0.87
|
|
48
|
A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
|
Int J Technol Assess Health Care
|
2009
|
0.87
|
|
49
|
Does physical activity reduce seniors' need for healthcare?: a study of 24 281 Canadians.
|
Br J Sports Med
|
2009
|
0.86
|
|
50
|
Economic and humanistic burden of external genital warts.
|
Pharmacoeconomics
|
2012
|
0.86
|
|
51
|
Ten-Year Trends in Direct Costs of COPD: A Population-Based Study.
|
Chest
|
2015
|
0.86
|
|
52
|
Antibiotic consumption in children prior to diagnosis of asthma.
|
BMC Pulm Med
|
2011
|
0.86
|
|
53
|
Cost-effectiveness of LTBI treatment for TB contacts in British Columbia.
|
Value Health
|
2008
|
0.85
|
|
54
|
Randomized controlled trial evaluating pictogram augmentation of HIV medication information.
|
Ann Pharmacother
|
2011
|
0.84
|
|
55
|
Quality-of-life assessment in an outpatient parenteral antibiotic program.
|
Ann Pharmacother
|
2002
|
0.84
|
|
56
|
A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.
|
Can Respir J
|
2003
|
0.83
|
|
57
|
Exploring patients' perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study.
|
Patient Prefer Adherence
|
2010
|
0.83
|
|
58
|
The economics of treatment in early rheumatoid arthritis.
|
Best Pract Res Clin Rheumatol
|
2009
|
0.83
|
|
59
|
A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework.
|
Pharmacoepidemiol Drug Saf
|
2010
|
0.82
|
|
60
|
Levofloxacin treatment of active tuberculosis and the risk of adverse events.
|
Chest
|
2005
|
0.81
|
|
61
|
An economic evaluation of resistance training and aerobic training versus balance and toning exercises in older adults with mild cognitive impairment.
|
PLoS One
|
2013
|
0.80
|
|
62
|
Comparison of HRQL between unicompartmental knee arthroplasty and total knee arthroplasty for the treatment of osteoarthritis.
|
J Arthroplasty
|
2013
|
0.80
|
|
63
|
The issue of comparators in economic evaluations of biologic response modifiers in rheumatoid arthritis.
|
Best Pract Res Clin Rheumatol
|
2012
|
0.80
|
|
64
|
Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
|
Diabetes Technol Ther
|
2009
|
0.80
|
|
65
|
Patterns of use and patients' attitudes toward complementary medications: a survey of adult general medicine patients at a major Canadian teaching hospital.
|
Can J Clin Pharmacol
|
2002
|
0.79
|
|
66
|
Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment.
|
Value Health
|
2011
|
0.78
|
|
67
|
Does antibiotic exposure during infancy lead to development of asthma? A systematic review and metaanalysis. 2006.
|
Chest
|
2009
|
0.78
|
|
68
|
Evolution of clinical pharmacy in the practice of rheumatology.
|
Ann Pharmacother
|
2007
|
0.78
|
|
69
|
Responses to comments of Weis.
|
Health Qual Life Outcomes
|
2010
|
0.78
|
|
70
|
Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis.
|
Pharmacotherapy
|
2007
|
0.77
|
|
71
|
Is surgical fixation for stress-positive unstable ankle fractures cost effective? Results of a multicenter randomized control trial.
|
J Orthop Trauma
|
2012
|
0.77
|
|
72
|
Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
|
Expert Rev Pharmacoecon Outcomes Res
|
2007
|
0.77
|
|
73
|
Sustained economic benefits of resistance training in community-dwelling senior women.
|
J Am Geriatr Soc
|
2011
|
0.76
|
|
74
|
Patient reported outcomes for rheumatoid arthritis: where are we and where are we going?
|
J Rheumatol
|
2008
|
0.76
|
|
75
|
Challenges in measuring the societal value of orphan drugs: insights from a canadian stated preference survey.
|
Patient
|
2015
|
0.76
|
|
76
|
Responsiveness of health state utility values in knee osteoarthritis.
|
J Rheumatol
|
2013
|
0.76
|
|
77
|
Diagnostic strategies incorporating computed tomography angiography for pulmonary embolism: a systematic review of cost-effectiveness analyses.
|
J Thorac Imaging
|
2014
|
0.76
|
|
78
|
Authors' response to "comparative effectiveness and personalized medicine" by Dr. J.C. Hornberger.
|
Value Health
|
2013
|
0.75
|
|
79
|
Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
|
Trials
|
2014
|
0.75
|
|
80
|
Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
81
|
The Impact of Price-cap Regulations on Exit by Generic Pharmaceutical Firms.
|
Med Care
|
2016
|
0.75
|
|
82
|
Economic evaluations of anticoagulants for the prophylaxis of venous thromboembolism following major trauma.
|
Expert Rev Pharmacoecon Outcomes Res
|
2007
|
0.75
|
|
83
|
Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.
|
Expert Rev Pharmacoecon Outcomes Res
|
2013
|
0.75
|
|
84
|
Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes.
|
Pharmacoeconomics
|
2014
|
0.75
|
|
85
|
Influence of standardized orders on postoperative nausea and vomiting after gynecologic surgery.
|
Ann Pharmacother
|
2002
|
0.75
|
|
86
|
Health economic evaluation: a primer for the practicing rheumatologist.
|
Arthritis Rheum
|
2006
|
0.75
|